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The combination of increased urinary oxalate and attenuated urinary citrate con-
centration are a major risk factor for Ca2þ-oxalate kidney stone formation, even
when urinary Ca2þ levels are not elevated. Nevertheless, the molecular mecha-
nisms that regulate urinary oxalate and citrate levels are notwell understood.We
studied the role of the oxalate transporter, slc26a6, and the citrate transporter,
NaDC-1, in regulating oxalate/citrate homeostasis. We found that Slc26a6-
null mice exhibited increased renal and intestinal sodium-dependent succinate
uptake which is attributed to NaDC-1 function. Furthermore, we monitored uri-
nary hyperoxaluria and hypocitraturia, but no change in urinary pH, indicating
enhanced transport activity of NaDC-1 in slc26a6-null mice. When co-
expressed in xenopus oocytes, Slc26a6 dramatically inhibitedNaDC-1 transport
activity in an activity dependentmanner. Finally, biochemical and physiological
analysis revealed that the STASdomainof Slc26a6 and thefirst intracellular loop
of NaDC-1mediated both the physical and functional interactions of these trans-
porters. Our findings reveal a molecular pathway that tightly regulates oxalate
and citrate concentration and may control biological Ca2þ-oxalate stone forma-
tion in the kidney and other organs like, for example, salivary glands.
2319-Pos Board B456
Assessing Protomer Independence of the Dimeric C4-Dicarboxylate Trans-
porter, Vcindy
Christopher Mulligan, Gabriel A. Fitzgerald, Joseph A. Mindell.
NINDS, NIH, Bethesda, MD, USA.
The divalent anion:sodium symporter (DASS) family includes characterized
representatives from bacteria and humans (SLC13 family). DASS family
members have been implicated in key physiological roles, including fatty
acid synthesis and the transport of Krebs cycle intermediates and sulfate
across the cytoplasmic membrane. Disruption of genes encoding DASS fam-
ily members in mice and flies reveal roles in energy homeostasis, affecting
lifespan determination, insulin resistance and obesity in these organisms.
VcINDY, from the bacterium Vibrio cholerae is the only DASS family member
for which there is high resolution structural information available and func-
tional characterization reveals VcINDY to share key functional characteristics
with mammalian DASS family members. VcINDY is a functional dimer exhib-
iting a large buried surface area at the dimer interface; a feature likely shared by
all DASS family members. Characterization of other bacterial members of the
family suggests cooperativity between the protomers. This apparent inter-
protomer communication is likely transmitted via substrate-induced conforma-
tional changes at the dimer interface. If true, this has important mechanistic im-
plications for the entire family.
To investigate whether transport by VcINDY is a cooperative process we have
introduced cysteine residues at the dimer interface that, under oxidizing condi-
tions or in the presence of crosslinking agents, will staple regions of the inter-
face together, limiting protein movement. Using this procedure we have
demonstrated that pinning the interface together in several regions does not
abrogate transport activity, indicating that no obligatory conformational
changes occur across the dimer interface during transport. Although further
confirmatory work is required, these data suggest that the VcINDY protomers
function independently of one another during the transport cycle.
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Organic cation transporters (OCTs) are polyspecific, facilitative transporterswith
major roles in metabolite and drug clearance. OCT1 and OCT2 are expressed in
hepatocytes and proximal tubular cells,whereasOCT3 is in astrocytes.OCT1 and
OCT2 have been well-studied, but the pharmacology and structure-function
relationships of OCT3 remain obscure. Previously, we screened polyamine com-
pounds for transport and competition against model substrate methyl-4-
phenylpyridinium (MPPþ) in OCT-expressing Xenopus oocytes, and established
that polyamines are transported substrates for OCTs, and that hydrophobicity is a
principal requirement for recognition of polycationic substrates and inhibitors.
OCT3 exhibited significantly higher requirements for hydrophobicity than other
isoforms. Here, we investigated the implications of key residues in shaping the
distinct selectivity profile of rat and humanOCT3.Homologymodeling identified
a putativehydrophobic cleft inOCTs capable of accommodating awide variety ofstructures and that all isoforms share a conserved Asp within this pocket (D478).
Replacement of this residuewith Arg, Asn or evenGlu drastically reducedMPPþ
uptake, suggesting that this Asp residue is obligatory for OCT3-mediated trans-
port, and may help stabilize positively charged substrates. Several key residues
within theOCT1 andOCT2 binding pocket are not conserved inOCT3, and these
differencesmight account formore stringent requirements inOCT3.Mutations at
these sites in OCT3 to the corresponding residue in OCT1 and OCT2 (L166F,
F450L and E451Q) intrinsically decreased MPPþ uptake rate. Potent OCT1
and OCT2 blockers tetraethylammonium (TEA) and 1,10-diaminodecane
(DA10) interact weakly with wild-type OCT3. There was no enhancement of
TEAorDA10block inmutant OCT3; rather,MPPþ uptake rate increased in pres-
ence of these compounds. These results suggest that these residues may help sta-
bilize substrates within the transporter and imply a more complex interaction
between substrates than simple competition for a single site.
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The ‘‘solubilization’’ procedure in which membrane proteins are extracted from
their native lipid membranes and transferred into detergent micelles (proteomi-
celles) is a critical step in the purification of the protein for subsequent structure/
function studies. In some notable examples it has become clear, however, that the
properties of the proteins in proteomicelles depend on the detergent type and its
concentration relative to the residual membrane lipids originating from the prep-
aration. To reveal themolecular mechanism of the solubilization process and the
effect of various lipid-to-detergent (L-D) ratios on the properties of the system,
we performed extensive atomistic molecular dynamics simulations. We previ-
ously explored the properties of micelles formed by dodecyl-b-maltoside
(DDM) detergent around the leucine transporter (LeuT), a bacterial homolog
of the neurotransmitter:sodium symporter family, and showed how the DDM
concentrationdetermines the extent of detergent penetration into the functionally
relevant secondary substrate (S2) binding site in LeuT. Here we present compu-
tational studies of LeuT embedded in proteomicelles at different L-D ratios
exploring configurations of LeuTproteomicelles at different stages of the protein
solubilization process. Our results reveal that at a sparse lipid annulus around the
transporter, consisting of nomore than ~10 lipids, DDMpartitions into the LeuT,
engaging with the residues in the S2 site. Higher lipid concentrations protect the
S2 site from DDM penetration. In contrast to DDM, MNG-3 (lauryl maltose-
neopentyl glycol) detergent, an amphiphile known to better stabilize membrane
proteins, does not penetrate the transporter even in the absence of lipids. Parallel
experimental measurements of ligand binding to LeuT in the presence of
increasing MNG-3 concentrations revealed that the functionality of the S2 site
was fully preserved even at the highest (0.5%) MNG-3 concentration probed.
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Neurotransmitter transporter are found on the presynaptic neurons and on glial
cells. The function of these transporters is termination of neurotransmission by
the rapid removal of neurotransmitter molecules from the synaptic cleft. These
transporters couple substrate transport to ion gradients of sodium and chloride.
Structural studies often require the transporter to be removed from its physi-
ological membrane, which can affect its structure or conformation. Crystal
structures of the bacterial homolog LeuT (SLC6 family) were solved in three
states of the transport cycle: occluded, outward and inward. The recent inward
facing structure shows a conformation where the first helix (TM1A) did not
seem to be compatible with a membrane environment. We carried out molec-
ular dynamics simulations of LeuT in membrane and micelle environment to
investigate the conformational behaviour of TM1A and combined the investi-
gation with distance measurements using LRET. We used POPC as membrane
lipids, and build the micelle systems with three different protein-detergent ra-
tios (1:120, 1:140, or 1:160) using the detergent n-Octyl-b-D-Glucopyrano-
side (BOG) molecules. We observed a rigid body motion of the TM1A
helix: it moves out of the hydrophobic core of the membrane. In contrary,
TM1A was stable in its position in the micelle simulations. We confirmed
this observation by distance measurements of solubilized LeuT in micelles
and reconstituted POPC liposomes. This study suggests that the polar part
462a Tuesday, February 10, 2015of TM1A helix would not protrude into the membrane core. To further char-
acterize the conformation of the TM1A helix, we used SMD simulations and
pulled this helix relative to the scaffold or the core domain. The free energy
profile was also endorsed our findings in the position of TM1A. These study
indicates that changes in the environment can affect the equilibrium confor-
mation of LeuT.
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The existence of a solved structure for a dopamine transporter drastically
changes the landscape for investigation of the mechanism of monoamine trans-
porter function. While previous structures for LeuT have shed light on transport
mechanisms, and though LeuT shares considerable structural overlap with
dDAT, LeuT has no corresponding electrophysiology. The new structure there-
fore has the advantage of correlating structure and function to help unravel the
outstanding mystery of transporters as channels, which has well developed cor-
relates in the ClC class of Cl- channels but no equivalent in monoamine
transporters.
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Dopamine transporter (DAT) controls neurotransmitter dopamine homeostasis
by pumping excess extracellular (EC) dopamine into presynaptic neurons to pre-
vent neurotoxicity. The process is assisted by co-transport of two sodiumand one
chloride ions.Malfunction ofDAThas been implicated inmanydiseases, such as
Parkinson’s disease and attention deficit hyperactivity disorder. Significant ad-
vances have been made in the characterization of the structure and dynamics
of a prokaryotic orthologue, LeuT, although the molecular mechanism of dopa-
mine translocation through human DAT (hDAT) remains elusive. Recently, the
first eukaryotic DAT structure was resolved from Drosophila melanogaster, in
the outward-facing open (OFo) state. Using homology modeling and unbiased
molecular dynamics simulations, we elucidated the sequence of molecular
events involved in dopamine translocation by hDAT, including the uptake
from the EC medium, closure of the EC gates upon dopamine binding, passage
over a holo-occluded intermediate temporarily stabilized via concerted changes
in the relative orientations of the TMhelices, subsequent opening of the intracel-
lular vestibule, release of co-transported ions, and succeeding discharge of dopa-
mine uponweakening the electrostatic attractions by aspartates near the binding-
site. The transport events revealedby these hDATsimulations showstriking con-
sistency with those disclosed in recent investigation of LeuT transport cycle (1,
2). The study sheds light for the first time at the mechanism of DAT functioning
at the atomic level and provides insights intomethods for modulating its interac-
tions with drugs and other substrate proteins.
1. Cheng, M.H. and I. Bahar. 2014. Complete mapping of substrate transloca-
tion highlights the role of LeuT N-terminal segment in regulating transport cy-
cle, PLoS Comput Biol. in press.
2. Cheng, M.H. and I. Bahar. 2013. Coupled global and local changes direct
substrate translocation by neurotransmitter-sodium symporter ortholog LeuT,
Biophys J. 105:630-9.
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In recent work, we employed a series of methylenedioxypyrovalerone (MDPV)
analogs to determine the structural determinants for the potent nature of MDPV
to inhibit uptake by the human dopamine transporter (hDAT). In hDAT-
expressing Xenopus laevis oocytes clamped to60 mV, MDPV and its analogs
induced comparable outward currents (attributed to a block of the endogenous
hDAT inward leak) that did not return to the original baseline after washout.
We recorded DA-induced hDAT currents before and after application of either
MDPV or its analogs, and obtained individual amplitude recovery profiles rela-
tive to the initial DA-induced currents, which correlated with the compounds’
potency to inhibit DA uptake via hDAT. Interestingly, for all compounds, afterwashout of the second DA application, the hDAT-mediated shift in baseline re-
turned to the elevated level. Moreover, for two MDPV analogs the second DA
response recovered 100% of the first DA response even if the baseline had
shifted. Furthermore, the shift in baseline produced by one of these analogs
was not impeded by the presence of a high concentration of dopamine. These
results suggest two distinct sites of action for drugs targeting DAT. We em-
ployed electrophysiology to characterize this secondary site of action, and ho-
mology models of hDAT based on the crystal structure of a bacterial leucine
transporter (LeuT) combined with docking simulations to identify the second-
ary binding site of MDPV and MDPV analogs.
Support: NIH 5R01DA033930-03 and 3R01DA033930-02S1
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The uptake and storage of neurotransmitters in synaptic vesicles is carried out by
neurotransmitter transporters from, e.g., the vesicular monoamine transporter
(VMAT) family, which allow regulated release of monoamines from the presyn-
aptic neuron into the synaptic cleft. Phylogenetic analysis reveals that VMAT
proteins are evolutionarily related to bacterial multidrug transporters involved
in antibiotic resistance. In fact, VMATs are responsible for sequestering toxic
substrates such as MPPþ into vesicles, away from their primary site of action.
To understand the molecular mechanisms of transport by VMAT, we character-
ized a homologous transporter fromBrevibacillus brevis (BbMAT)usingmolec-
ular modeling and biochemical approaches. First, we built a homologymodel of
BbMAT based on the crystal structure of YajR, a putative proton-driven MFS
transporter fromEscherichia coli. As expected, themodel contains 12 transmem-
brane (TM) helices, arranged in two domains of 6TMs each,which are related by
2-fold pseudo-symmetry around an axis perpendicular to themembrane between
the twohalves. Themodel predicts that four carboxyl residues, a histidine, and an
arginine are located in the TM segments that line the central cavity. The activity
of BbMAT coupled to a proton gradient was assessed biochemically, demon-
strating that the transport process is electrogenic and therefore that at least two
protons are exchanged for each substrate. The six residues exposed to the
aqueous cavity according to themodel were thenmutated either alone or in com-
bination, and these mutants were tested for their ability to confer resistance to
ethidium and acriflavine. The results show that only two residues, D25 (TM1)
and E229 (TM7), are essential for proton-coupled transport in BbMAT. We
conclude that BbMAT is a paradigm for the study of multidrug and neurotrans-
mitter transport by VMATs.
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Monoamine transporters take up neurotransmitters, but they also release neuro-
transmitters when challenged by abused drugs like amphetamine (AMPH) or
MDMA (ecstasy). Transported substrates including transmitters and drugs
are accompanied by excess positive charges that constitute an inward, depola-
rizing current. Previous research suggests that dopamine transporter (DAT)
substrate-induced currents produce bursts of action potentials in dopaminergic
neurons. Both pace-making and action potential bursting are mediated by L-
type Ca2þ channels (CaV1.3) in several excitable cells, including some dopa-
minergic neurons, whereas N-type Ca2þ channels (CaV2.2) are mainly
involved in neurotransmitter release. Here we test the hypothesis that mono-
amine transporters are electrically coupled to L-type Ca2þ channels. We ex-
press the serotonin transporter (SERT) in wt and CaV1.1-null myoblasts.
After differentiation, wt myotubes, but not CaV1.1-null myotubes, release
Ca2þ after 5HT or S(þ)MDMA exposure, suggesting the participation of L-
type Ca2þ channels. This effect was sensitive to fluoxetine but refractory to
TTX, implicating SERT and excluding the participation of voltage-gated
Naþ channels. Furthermore, co-expression of SERT & CaV1.3 in HEK cells
supported Ca2þ signals, whereas SERT & CaV2.2 was unresponsive to 5HT
or S(þ)MDMA. Similarly, co-expression of DAT & CaV1.3 or DAT &
CaV1.2 supported Ca2þ signals induced by S(þ)AMPH or dopamine, whereas
DAT & CaV2.2 expression was refractory to both agents even though S(þ)
